Crystal structures of MMPs in complex with physiological and pharmacological inhibitors

Biochimie

Volumn 87, Issue 3-4 SPEC. ISS., 2005, Pages 249-263

  Maskos, Klaus ^a  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

Collagenase; Dimerization; Inhibition; Latency; Metalloprotease; MMP; Structure

Indexed keywords

COLLAGENASE 3; FIBRONECTIN; GELATINASE A; GELATINASE B; HEMOPEXIN; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 16; NEUTROPHIL COLLAGENASE; STROMELYSIN; STROMELYSIN 2; STROMELYSIN 3; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; ARTICLE; CATALYSIS; CRYSTAL STRUCTURE; DIMERIZATION; ENZYME ACTIVE SITE; ENZYME SPECIFICITY; HYDROPHOBICITY; NONHUMAN; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS;

EID: 15244343490     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biochi.2004.11.019     Document Type: Short Survey

References (84)

1. F.X. Gomis-Rüth Structural aspects of the metzincin clan of metalloendopeptidases Mol. Biotechnol. 24 2003 157 202
2. G. Murphy, and J. Gavrilovic Proteolysis and cell migration: creating a path? Curr. Opin. Cell Biol. 11 1999 614 621
3. M.D. Sternlicht, and Z. Werb How matrix metalloproteinases regulate cell behaviour Annu. Rev. Cell Dev. Biol. 17 2001 463 516
4. J. Oh, R. Takahashi, S. Kondo, A. Mizoguchi, E. Adachi, and R.M. Sasahara The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis Cell 107 2001 789 800
5. M.P. Herman, G.K. Sukhova, W. Kisiel, D. Foster, M.R. Kehry, and P. Libby Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis J. Clin. Invest. 107 2001 1117 1126
6. J.D. Mott, C.L. Thomas, M.T. Rosenbach, K. Takahara, D.S. Greenspan, and M.J. Banda Post-translational proteolytic processing of procollagen C-terminal proteinase enhancer releases a metalloproteinase inhibtor J. Biol. Chem. 275 2000 1384 1390
7. R.T. Lee Matrix metalloproteinase inhibition and the prevention of heart failure Trends Cardiovasc. Med. 11 2001 202 205
8. W.C. Parks, and S.D. Shapiro Matrix metalloproteinases in lung biology Respir. Res. 2 2001 10 19
9. H.D. Foda, and S. Zucker Matrix metalloproteinases in cancer invasion, metastasis and angiogenesis Drug Discov. Today 6 2001 478 482
10. I. Stamenkovic Extracellular matrix remodelling: the role of matrix metalloproteinases J. Pathol. 200 2003 448 464
11. A. Dove MMP inhibitors: glimmers of hope amidst clinical failures Nat. Med. 8 2002 95
12. J.L. Beaudeux, P. Giral, E. Bruckert, M.J. Foglietti, and M.J. Chapman Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives Clin. Chem. Lab. Med. 42 2004 121 131
13. N. Ramnath, and P.J. Creaven Matrix metalloproteinase inhibitors Curr. Oncol. Rep. 6 2004 96 102
14. W. Bode, F.X. Gomis-Rüth, and W. Stöcker Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc-binding environments (HEXXHXXGXXH and Met-turn) and topologies and should be grouped into a common family, the "metzincins" FEBS Lett. 331 1993 134 140
15. W. Stocker, F. Grams, U. Baumann, P. Reinemer, F.X. Gomis-Ruth, and D.B. McKay The metzincins--topological and sequential relations between the astacins, adamalysins, serralysins and matrixins (collagenases) define a superfamily of zinc-peptidases Prot. Sci. 4 1995 823 840
16. C.M. Overall Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinase substrate binding domains, modules and exosites Mol. Biotechnol. 22 2002 51 86
17. H. Sato, T. Takino, Y. Okada, J. Cao, A. Shinagawa, and E. Yamamoto A matrix metalloproteinase expressed on the surface of invasive tumour cells Nature 370 1994 61 65
18. Y. Itoh, M. Kajita, H. Kinoh, H. Mori, A. Okada, and M. Seiki Membrane type 4 matrix metalloproteinase (MT4-MMP, MMP-17) is a glycosylphosphatidylinositol-anchored proteinase J. Biol. Chem. 274 1999 34260 34266
19. K. Brew, D. Dinakarpandian, and H. Nagase Tissue inhibitors of metalloproteinases: evolution, structure and function Biochim. Biophys. Acta 1477 2000 267 283
20. H. Will, S.J. Atkinson, G.S. Butler, B. Smith, and G. Murphy The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3 J. Biol. Chem. 271 1996 17119 17123
21. M.H. Lee, M. Rapti, and G. Murphy Unveiling the surface epitopes that render tissue inhibitor of metalloproteinases-1 inactive against membrane type 1-matrix metalloproteinase J. Biol. Chem. 278 2003 40224 40230
22. M. Hutton, F. Willenbrock, K. Brocklehurst, and G. Murphy Kinetic analysis of the mechanism of interaction of full-length TIMP-2 and gelatinase A: evidence for the existence of a low-affinity intermediate Biochemistry 37 1998 10094 10098
23. Y. Ogata, Y. Itoh, and H. Nagase Steps involved in activation of the pro-matrix metalloproteinase 9 (progelatinase B)- tissue inhibitor of metalloproteinases-1 complex by 4-aminophenylmercuric acetate and proteinases J. Biol. Chem. 270 1995 18506 18511
24. R.V. Ward, S.J. Atkinson, and G. Murphy Cell surface-mediated activation of progelatinase A: demonstration of the involvement of the C-terminal domain of progelatinase A in cell surface binding and activation of progelatinase A by primary fibroblasts Biochem. J. 304 1994 263 269
25. E. Morgunova, A. Tuuttila, U. Bergmann, and K. Tryggvason Structural insight into the complex formation of latent matrix metalloproteinase 2 with the tissue inhibitor of metalloproteinase 2 Proc. Natl. Acad. Sci. USA 99 2002 7414 7419
26. G.S. Butler, S.S. Apte, F. Willenbrock, and G. Murphy Human tissue inhibitor of metalloproteinases 3 interacts with both the N- and C-terminal domains of gelatinases A and B J. Biol. Chem. 274 1999 10846 10851
27. K. Maskos, C. Fernandez-Catalan, R. Huber, G.P. Bourenkov, H. Bartunik, and G.A. Ellestad Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme Proc. Natl. Acad. Sci. USA 95 1998 3408 3412
28. P. Orth, P. Reichert, W. Wang, W.W. Prosise, T. Yarosh-Tomaine, and G. Hammond Crystal structure of the catalytic domain of human ADAM33 J. Mol. Biol. 335 2004 129 137
29. D. Jozic, G. Bourenkov, N.H. Lim, R. Visse, H. Nagase, and W. Bode X-ray structure of human proMMP-1: new insights into procollagenase activation and collagen binding J. Biol. Chem. 2004 Epub Dec 15.
30. E. Morgunova, A. Tuuttila, U. Bergmann, M. Isupov, Y. Lindqvist, and G. Schneider Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed Science 284 1999 1667 1670
31. J. Li, P. Brick, M.C. O'Hare, T. Skarzynski, L.F. Lloyd, and V.A. Curry Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium-linked, four-bladed beta-propeller Structure 3 1995 541 549
32. M. Pieper, M. Betz, N. Budisa, F.X. Gomis-Rüth, W. Bode, and H. Tschesche Expression, purification, characterization and X-ray analysis of selenomethionine 215 variant of leukocyte collagenase J. Prot. Chem. 16 1997 637 650
33. G.S. Butler, E.M. Tam, and C. Overall The canonical methionine 392 of matrix metalloproteinase 2 (gelatinase A) is not required for catalytic efficiency or structural integrity J. Biol. Chem. 279 2004 15615 15620
34. H. Nagase Activation mechanisms of matrix metalloproteinases Biol. Chem. 378 1997 151 160
35. R. Lang, A. Kocourek, M. Braun, H. Tschesche, R. Huber, W. Bode, and K. Maskos Substrate specificity determinants of human macrophage elastase (MMP-12) based on the 1.1 A crystal structure J. Mol. Biol. 312 2001 731 742
36. W. Bode, and K. Maskos Matrix metalloproteinases A. Messerschmidt W. Bode M. Cygler Handbook of Metalloproteins 2004 John Wiley & Sons Chichester, England 130 147
37. J. Cha, M.V. Pedersen, and D.S. Auld Metal and pH dependence of heptapeptide catalysis by human matrilysin Biochemistry 35 1996 15831 15838
38. F. Grams, P. Reinemer, J.C. Powers, T. Kleine, M. Pieper, and H. Tschesche X-ray structure of human neutrophil collagenase complexed with peptide hydroxamate and peptide thiol inhibitors. Implications for substrate binding and rational drug design Eur. J. Biochem. 228 1995 830 841
39. R. Lang, M. Braun, N.E. Sounni, A. Noel, F. Frankenne, and J.M. Foidart Crystal structure of the catalytic domain of MMP-16/MT3-MMP: characterization of MT-MMP specific features J. Mol. Biol. 336 2004 213 225
40. B. Lovejoy, A.R. Welch, S. Carr, C. Luong, C. Broka, and T. Hendricks Crystal structures of MMP-1 and -13 reveal the structural basis for selectivity of collagenase inhibitors Nat. Struct. Biol. 6 1999 217 221
41. L. Chung, K. Shimokawa, D. Dinakarpandian, F. Grams, G.B. Fields, and H. Nagase Identification of the (183)RWTNNFREY(191) region as a critical segment of matrix metalloproteinase 1 for the expression of collagenolytic activity J. Biol. Chem. 275 2000 29610 29617
42. H. Brandstetter, F. Grams, D. Glitz, A. Lang, R. Huber, and W. Bode The 1.8-Å crystal structure of a matrix metalloproteinase 8-barbiturate inhibitor complex reveals a previously unobserved mechanism for collagenase substrate recognition J. Biol. Chem. 276 2001 17405 17412
43. B.W. Matthews Structural basis of the action of thermolysin and related zinc peptidases Acc. Chem. Res. 21 1988 333 340
44. K. Suzuki, J.J. Enghild, T. Morodoni, G. Salvesen, and H. Nagase Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin) Biochemistry 29 1990 10261 10270
45. S.J. Atkinson, T. Crabbe, S. Cowell, R.V. Ward, M. Butler, and H. Sato Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes J. Biol. Chem. 270 1995 30479 30485
46. N.D. Marchenko, G.N. Marchenko, and A.Y. Strongin Unconventional activation mechanisms of MMP-26, a human matrix metalloproteinase with a unique PHCGXXD cysteine-switch motif J. Biol. Chem. 277 2002 18967 18972
47. D. Pei, T. Kang, and H. Qi Cysteine array matrix metalloproteinase (CA-MMP)/MMP-23 is a type II transmembrane matrix metalloproteinase regulated by a single cleavage for both secretion and activation J. Biol. Chem. 275 2000 33988 33997
48. H.R. Faber, C.R. Groom, H.M. Baker, W.T. Morgan, A. Smith, and E.N. Baker 1.8 Å crystal structure of the C-terminal domain of rabbit serum haemopexin Structure 3 1995 551 559
49. J.A. Curci, S. Liao, M.D. Huffmann, S.D. Shapiro, and R.W. Thompson Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms J. Clin. Invest. 102 1998 1900 1910
50. G. Murphy, J.A. Allan, F. Willenbrock, M.I. Cockett, J.P. O'Connel, and A.J. Docherty The role of the C-terminal domain in collagenase and stromelysin specificity J. Biol. Chem. 267 1992 9612 9618
51. U. Gohlke, F.-X. Gomis-Rüth, T. Crabbe, G. Murphy, A.J.P. Docherty, and W. Bode The C-terminal (haemopexin-like) domain structure of human gelatinase A (MMP-2): structural implications for its function FEBS Lett. 378 1996 126 130
52. F.X. Gomis-Rüth, U. Gohlke, M. Betz, V. Knauper, G. Murphy, and C. Lopes-Otin A helping hand of collagenase-3 (MMP-13): 2.7 Å crystal structure of its C-terminal haemopexin-like domain J. Mol. Biol. 264 1996 556 566
53. L. Chung, D. Dinakarpandian, N. Yoshida, J.L. Lauer-Fields, G.B. Fields, and R. Visse Collagenase unwinds triple-helical collagen prior to peptide bond hydrolysis EMBO J. 23 2004 3020 3030
54. E.M. Tam, T.R. Moore, G.S. Butler, and C.M. Overall Characterization of the distinct collagen binding and cleavage mechanisms of matrix metalloproteinase 2 and 14 (gelatinase A and MT1-MMP): the differential roles of the MMP hemopexin C domains and the MMP-2 fibronectin type II modules in collagen triple helicase activities J. Biol. Chem. 279 2004 43336 43344
55. V. Knauper, A.J. Docherty, B. Smith, H. Tschesche, and G. Murphy Analysis of the contribution of the hinge region of human neutrophil collagenase (HNC, MMP-8) to stability and collagenolytic activity by alanine scanning mutagenesis FEBS Lett. 405 1997 60 64
56. H. Tsukada, and T. Pourmotabbed Unexpected crucial role of residue 272 in substrate specificity of fibroblast collagenase J. Biol. Chem. 277 2002 27378 27384
57. K. Briknarova, A. Grishaev, L. Banyai, H. Tordai, L. Patthy, and M. Llinas The second type II module from human matrix metalloproteinase-2: structure, function and dynamics Struct. Fold. Des. 7 1999 1235 1245
58. K. Briknarova, M. Gehrmann, L. Banyai, H. Tordai, L. Patty, and M. Llinas Gelatin-binding region of human matrix metalloproteinase-2 J. Biol. Chem. 276 2001 27613 27621
59. M. Gehrmann, K. Briknoarova, L. Banyai, L. Patty, and M. Llinas The col-1 module of human matrix metalloproteinase-2 (MMP-2): structural/functional relatedness between gelatin-binding fibronectin type II modules and lysine-binding kringle domains Biol. Chem. 383 2002 137 148
60. F.X. Gomis-Ruth, K. Maskos, M. Betz, A. Bergner, R. Huber, and K. Suzuki Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1 Nature 389 1997 77 81
61. R.A. Williamson, G. Martorell, M.D. Carr, G. Murphy, A.J. Docherty, and R.B. Freedman Solution structure of the active domain of tissue inhibitor of metalloproteinases-2. A new member of the OB fold family Biochemistry 33 1994 11745 11759
62. C.A. Fernandez, C. Butterfield, G. Jackson, and M.A. Moses Structural and functional uncoupling of the enzymatic and angiogenic inhibitory activities of tissue inhibitor of metalloproteinases-2 (TIMP-2) J. Biol. Chem. 278 2003 40989 40995
63. B. Lovejoy, A.M. Hassell, M.A. Luther, D. Weigl, and S.R. Jordan Crystal structures of recombinant 19:kDa human fibroblast collagenase complexed to itself Biochemistry 33 1994 8207 8217
64. G. Murphy, and F. Willenbrock Tissue inihibitors of matrix metalloendopeptidases Methods Enzymol. 248 1995 496 510
65. W. Huang, Q. Meng, K. Suzuki, H. Nagase, and K. Brew Mutational study of the amino-terminal domain of human tissue inhibitor of metalloproteinases 1 (TIMP-1) locates an inhibitory region for matrix metalloproteinases J. Biol. Chem. 272 1997 22086 22091
66. G. Murphy, and V. Knäuper Relating matrix metalloproteinase structure to function: why the "hemopexin" domain? Matrix Biol. 15 1997 511 518
67. V. Knäuper, S. Cowell, B. Smith, C. Lopez-Otin, M. O'Shea, and H. Morris The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction J. Biol. Chem. 272 1997 7608 7616
68. C. Fernandez-Catalan, W. Bode, R. Huber, D. Turk, J.J. Calvete, and A. Lichte Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor EMBO J. 17 1998 5238 5248
69. G.S. Butler, M. Hutton, B.A. Wattam, R.A. Williamson, V. Knauper, and F. Willenbrock The specificity of TIMP-2 for matrix metalloproteinases can be modified by single amino acid mutations J. Biol. Chem. 274 1999 20391 20396
70. H. Nagase, and K. Brew Designing TIMP (tissue inhibitor of metalloproteinases) variants that are selective metalloproteinase inhibitors Biochem. Soc. Sym. 70 2003 201 212
71. M.H. Lee, M. Rapti, V. Knauper, and G. Murphy Threonine 98, the pivotal residue of tissue inhibitor of metalloproteinases (TIMP)-1 in metalloproteinase recognition J. Biol. Chem. 279 2004 17562 17569
72. C.M. Overall, A.E. King, H.F. Bigg, A. McQuibban, J. Atherstone, and D.K. Sam Identification of the TIMP-2 binding site on the gelatinase A hemopexin C-domain by site-directed mutagenesis and the yeast two-hybrid system Ann. N. Y. Acad. Sci. 878 1999 747 753
73. Y. Itoh, A. Takamura, N. Ito, Y. Maru, H. Sato, and N. Suenaga Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion EMBO J. 20 2001 4782 4793
74. K. Maskos, and W. Bode Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases Mol. Biotechnol. 25 2003 241 266
75. H. Cha, E. Kopetzki, R. Huber, M. Lanzendorfer, and H. Brandstetter Structural basis of the adaptive molecular recognition by MMP9 J. Mol. Biol. 320 2002 1065 1079
76. G.A. McQuibban, J.H. Gong, E. Tam, C.A.G. McCulloch, I. Clark-Lewis, and C. Overall Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3 Science 289 2000 1202 1206
77. M.W. Olson, M.M. Bernardo, M. Pietila, D.C. Gervasi, M. Toth, and L.P. Kotra Characterization of the monomeric and dimeric forms of latent and active matrix metalloproteinase-9. Differential rates for activation by stromelysin 1 J. Biol. Chem. 275 2000 2661 2668
78. K. Lehti, J. Lohi, M.M. Juntunen, D. Pei, and J. Keski-Oja Oligomerization through hemopexin and cytoplasmic domains regulates the activity and turnover of membrane-type 1 matrix metalloproteinase J. Biol. Chem. 277 2002 8440 8448
79. J.A. Dumin, S.K. Dickeson, T.P. Stricker, M. Bhattacharyya-Pakrasi, J.D. Roby, and S.A. Santoro Pro-collagenase-1 (matrix metalloproteinase-1) binds the alpha(2)beta(1) integrin upon release from keratinocytes migrating on type I collagen J. Biol. Chem. 276 2001 29368 29374
80. T.P. Stricker, J. Dumin, L. Chung, H. Nagase, W.C. Parks, and S.A. Santoro Structural analysis of the α2 integrin I domain/procollagenase-1 (Matrix Metalloproteinase-1) interaction J. Biol. Chem. 276 2001 29375 29381
81. Q. Yu, and I. Stamenkovic Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion Genes Dev. 13 1999 35 48
82. M.W. Olson, M. Toth, D.C. Gervasi, Y. Sado, Y. Ninomiya, and R. Fridman High affinity binding of latent matrix metalloproteinase-9 to the alpha2(IV) chain of collagen IV J. Biol. Chem. 273 1998 10672 10681
83. P.C. Brooks, S. Stromblad, L.C. Sanders, T.L. Von Schalscha, R.T. Aimes, and W.G. Stetler-Stevenson Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3 Cell 85 1996 683 693
84. M. Stefanidakis, M. Bjorklund, E. Ihanus, C.G. Gahmberg, and E. Koivunen Identification of a negatively charged peptide motif within the catalytic domain of progelatinases that mediates binding to leukocyte beta 2 integrins J. Biol. Chem. 278 2003 34674 34684